Videos

Anat Loewenstein, MD, shared recent research findings which indicate home monitoring is appropriate for atypical and complex pathologies

Continued research shows that earlier treatment significantly enhances tissue preservation in patients with geographic atrophy, emphasizing the importance of timely intervention.

Dr Khanani shared his first-time results talk during an AAO specialty day

Dr Borkar, a vitreoretinal surgeon at Duke University, spoke to the Eye Care Network about her American Academy of Ophthalmology (AAO) presentation

Jean-Francois Korobelnik, MD, shares highlights from the PULSAR extension study showcasing aflibercept 8 mg and its ability to promote fluid resolution

An expert discusses the prevalence and clinical impact of Demodex blepharitis across Japan and Europe, highlighting regional differences in diagnosis and awareness.

Dr Chhablani said "having multiple approaches to the same problem" is key for reaching the maximum number of patients with age-related macular degeneration

Dr Miere presented the ACTOR study, illuminating vascular remodeling in patients with neovascular AMD, and the HERMES study, investigating perfusion changes in central retinal vein occlusion

María Berrocal, MD, spoke about the Vit-Buckle Society (VBS), which has become a regular feature at the European Society of Retina Specialists annual meeting

Prof Romano stressed the importance of matching procedure to patient, not just mastering technical vitrectomy skills

An expert discusses evolving best practices in the diagnosis and management of Demodex blepharitis, highlighting collarettes as pathognomonic and sufficient for diagnosis, the importance of targeting high-risk patient groups for treatment, and the promise of a new pharmacologic therapy that shifts care toward a more effective, flexible, and patient-centered approach.

Today, over 150 practitioners from 20 countries in Australia, Asia and Europe enter their patient data into the Fight Retinal Blindness! Registry

At the EURETINA congress, Prof Boon discussed controversies in treatment, some driven by critical prospective studies

Artificial intelligence is quickly expanding the breadth and depth of information clinicians can interpret, Prof Uy said

Prof Stanzel detailed new advancements in proliferative vitreoretinopathy and a hyperaspheric IOL designed for patients with age-related macular degeneration

Discover how the International Retinal Imaging Society fosters collaboration among specialists to advance retinal imaging and transform clinical practices.

The Vit-Buckle Symposium fosters global collaboration among eye care professionals, emphasizing interactive learning through challenging surgical case discussions.

This year's EURETINA meeting boasts a crowd of 10,000 attendees, including delegates, industry leaders, and young retina specialists.

Jeremiah Tao, MD, FACS, used his Egyptian Ophthalmological Society keynote to explore complex and costly challenges in oculofacial surgery

A 12-month follow-up indicated no dose limiting toxicity and no ocular or systemic adverse effects

João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases

Christine A. Curcio, PhD, shares an update on histology and its critical role in advancing <3 μm optical coherence tomography interpretation

High-resolution optical coherence tomography illuminates crucial biomarkers in age-related macular degeneration, Dr Sadda said

FLIO ushers clinicians from structural to functional imaging, said Robert Sergott, MD, in a presentation at the International SPECTRALIS Symposium

In the second of two video interviews from the International SPECTRALIS Symposium, Prof Malik emphasises the importance of corneal imaging

Anat Loewenstein, MD, presented real-world results of remote imaging at the International SPECTRALIS Symposium

Dr Brunstetter, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, delivered the lecture at this year's ISS alongside his colleague Warren Hoburg

Prof Malik shared his presentation, titled "An eye on neurodegenerative diseases: Challenging the dogma," at this year's International SPECTRALIS Symposium